ReviewCancer management and research2020

Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data.

Krista Isaac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.